Heffernan Michael Thomas — SEC insider filings

SEC reporting owner CIK 1448914. 39 insider filings on record with FilingPulse; latest filed 2026-09-17.

Transaction summary — filings shown

Covers all 39 filings on record, filed 2020-08-12 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
COLLEGIUM PHARMACEUTICAL, INC (COLL)Director10—12 legs · 361,758 sh · $8,243,91931
Trevi Therapeutics, Inc. (TRVI)Director8—4 legs · 39,473 sh · $595,80611
Biohaven Ltd. (BHVN)Director6——17
Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Director5——9
SYNLOGIC, INC. (SYBX)Director4——4
Avalo Therapeutics, Inc. (AVTX)Director3——3
Akebia Therapeutics, Inc. (AKBA)Director1——2
enGene Therapeutics Inc. (ENGN)Director2——2

Insider filings — Heffernan Michael Thomas

FiledFormIssuerReported transactionsSource
2026-09-174Trevi Therapeutics, Inc. (TRVI)Option exercise (M): 18,421 @ $3.04 · Sale (S): 18,321 @ $15.09 · Sale (S): 100 @ $15.88 · Option exercise (M): 21,052 @ $3.33 · Sale (S): 20,952 @ $15.09 · Sale (S): 100 @ $15.88 · +2 moreEDGAR
2026-06-174enGene Therapeutics Inc. (ENGN)Grant/award (A): 31,000 (derivative) @ $0EDGAR
2026-06-044Trevi Therapeutics, Inc. (TRVI)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2026-06-044Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 29,500 (derivative) @ $0EDGAR
2026-04-304Biohaven Ltd. (BHVN)Grant/award (A): 68,693 (derivative) @ $0EDGAR
2025-07-104enGene Holdings Inc. (ENGN)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2025-06-184Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 29,500 (derivative) @ $0EDGAR
2025-06-134Trevi Therapeutics, Inc. (TRVI)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2025-05-074Biohaven Ltd. (BHVN)Grant/award (A): 31,716 (derivative) @ $0EDGAR
2025-03-264Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2025-02-124COLLEGIUM PHARMACEUTICAL, INC (COLL)Grant/award (A): 4,820 @ $0EDGAR
2024-06-144Trevi Therapeutics, Inc. (TRVI)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2024-05-164COLLEGIUM PHARMACEUTICAL, INC (COLL)Grant/award (A): 7,693 @ $0EDGAR
2024-05-024Biohaven Ltd. (BHVN)Grant/award (A): 16,592 (derivative) @ $0EDGAR
2023-06-304Trevi Therapeutics, Inc. (TRVI)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2023-06-264SYNLOGIC, INC. (SYBX)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2023-05-194COLLEGIUM PHARMACEUTICAL, INC (COLL)Grant/award (A): 9,792 @ $0EDGAR
2023-05-044Biohaven Ltd. (BHVN)Grant/award (A): 52,906 (derivative) @ $0EDGAR
2022-12-274COLLEGIUM PHARMACEUTICAL, INC (COLL)Option exercise (M): 237 @ $16.15 · Sale (S): 237 @ $23 · Option exercise (M): 4,989 @ $16.15 · Sale (S): 4,989 @ $23 · Option exercise (M): 15,995 @ $16.15 · Sale (S): 15,995 @ $23.63 · +6 moreEDGAR
2022-12-214COLLEGIUM PHARMACEUTICAL, INC (COLL)Option exercise (M): 3,606 @ $16.15 · Sale (S): 3,606 @ $23.04 · Option exercise (M): 33,758 @ $16.15 · Sale (S): 33,758 @ $23.08 · Option exercise (M): 46,600 @ $16.15 · Sale (S): 46,600 @ $23.11 · +3 moreEDGAR
2022-12-144COLLEGIUM PHARMACEUTICAL, INC (COLL)Option exercise (M): 10,669 @ $14.90 · Option exercise (M): 15,741 @ $15.27 · Option exercise (M): 1,510 @ $14.57 · Sale (S): 27,920 @ $22.01 · Option exercise (M): 59,524 @ $14.90 · Option exercise (M): 94,259 @ $15.27 · +8 moreEDGAR
2022-10-124/ABiohaven Ltd. (BHVN)Tax withholding (F): 9,699 @ $7.50EDGAR
2022-10-054Biohaven Ltd. (BHVN)Other (J): 1,660 @ $0 · Option exercise (M): 4,119 @ $4.84 · Option exercise (M): 5,998 @ $3.56 · Option exercise (M): 13,100 @ $2.40 · Tax withholding (F): 5,507 @ $7.50 · Other (J): 4,119 (derivative) · +6 moreEDGAR
2022-10-034Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Disposition to issuer (D): 3,320 (derivative) · Disposition to issuer (D): 8,239 (derivative) · Disposition to issuer (D): 11,996 (derivative) · Disposition to issuer (D): 26,200 (derivative)EDGAR
2022-07-014/ATrevi Therapeutics, Inc. (TRVI)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-234Trevi Therapeutics, Inc. (TRVI)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-134SYNLOGIC, INC. (SYBX)Grant/award (A): 27,000 (derivative) @ $0EDGAR
2022-05-234COLLEGIUM PHARMACEUTICAL, INC (COLL)Grant/award (A): 14,035 @ $0EDGAR
2022-04-294Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Grant/award (A): 8,239 (derivative) @ $0EDGAR
2021-12-224Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Grant/award (A): 3,320 (derivative) @ $0EDGAR
2021-06-174Trevi Therapeutics, Inc. (TRVI)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2021-06-144SYNLOGIC, INC. (SYBX)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-06-034Akebia Therapeutics, Inc. (AKBA)Grant/award (A): 13,700 @ $0 · Grant/award (A): 20,100 (derivative) @ $0EDGAR
2021-05-244COLLEGIUM PHARMACEUTICAL, INC (COLL)Grant/award (A): 9,941 @ $0EDGAR
2021-05-074Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Grant/award (A): 11,996 (derivative) @ $0EDGAR
2021-03-264/ABiohaven Pharmaceutical Holding Co Ltd. (BHVN)Grant/award (A): 26,200 (derivative) @ $0 · Grant/award (A): 0 (derivative) @ $0EDGAR
2021-03-174COLLEGIUM PHARMACEUTICAL, INC (COLL)Sale (S): 47,044 @ $25.26 · Sale (S): 3,031 @ $25.88EDGAR
2020-12-094SYNLOGIC, INC. (SYBX)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2020-08-124COLLEGIUM PHARMACEUTICAL, INC (COLL)Sale (S): 13,071 @ $19.13EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1448914 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs